Koers ProMIS Neurosciences, Inc. Toronto S.E.
Aandelen
PMN
CA74346M4065
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 49,56 mln. 36,25 mln. 33,8 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -38 mln. -27,79 mln. -25,91 mln. | Nettowinst (verlies) 2025 * | -46 mln. -33,64 mln. -31,37 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,78
x | K/w-verhouding 2025 * |
-1,79
x | Werknemers | 7 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 75,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neil Warma
CEO | Chief Executive Officer | 61 | 13-05-21 |
Neil Cashman
FOU | Founder | 72 | 23-01-04 |
Eugene Williams
CHM | Chairman | 64 | 29-06-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
William W. Wyman
BRD | Director/Board Member | 86 | 08-03-14 |
Neil Cashman
FOU | Founder | 72 | 23-01-04 |
Neil Warma
CEO | Chief Executive Officer | 61 | 13-05-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,16% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-8,40% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |